Cite
MLA Citation
C. De Meijer et al.. “1223 Cost-effectiveness of radium-223 compared to best standard of care, abiraterone acetate and enzalutamide in the treatment of castration resistant prostate cancer in the Netherlands.” European journal of cancer, vol. 51, n.d., pp. S179–S180. http://access.bl.uk/ark:/81055/vdc_100030628104.0x00002e